William Blair & Company’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,723
Closed -$807K 1817
2024
Q3
$807K Sell
12,723
-2,309
-15% -$167K ﹤0.01% 966
2024
Q2
$1.02M Buy
15,032
+4,050
+37% +$283K ﹤0.01% 872
2024
Q1
$870K Buy
10,982
+12
+0.1% +$981 ﹤0.01% 913
2023
Q4
$853K Buy
10,970
+31
+0.3% +$2.29K ﹤0.01% 906
2023
Q3
$769K Hold
10,939
﹤0.01% 920
2023
Q2
$871K Buy
10,939
+1,546
+16% +$112K ﹤0.01% 884
2023
Q1
$679K Sell
9,393
-154
-2% -$12K ﹤0.01% 943
2022
Q4
$786K Sell
9,547
-3,563
-27% -$294K ﹤0.01% 911
2022
Q3
$1.02M Buy
13,110
+398
+3% +$31.8K ﹤0.01% 806
2022
Q2
$860K Sell
12,712
-435
-3% -$30.3K ﹤0.01% 900
2022
Q1
$862K Sell
13,147
-234
-2% -$13.6K ﹤0.01% 972
2021
Q4
$812K Sell
13,381
-6,933
-34% -$413K ﹤0.01% 1032
2021
Q3
$1.3M Sell
20,314
-1,686
-8% -$106K ﹤0.01% 823
2021
Q2
$1.38M Buy
22,000
+282
+1% +$17.7K ﹤0.01% 816
2021
Q1
$1.24M Buy
21,718
+5,563
+34% +$301K ﹤0.01% 833
2020
Q4
$812K Buy
16,155
+8,059
+100% +$321K ﹤0.01% 931
2020
Q3
$239K Sell
8,096
-1,709
-17% -$49.6K ﹤0.01% 1221
2020
Q2
$246K Buy
+9,805
New +$245K ﹤0.01% 1165
2020
Q1
Sell
-10,390
Closed -$345K 1653
2019
Q4
$345K Sell
10,390
-5,140
-33% -$161K ﹤0.01% 1127
2019
Q3
$483K Hold
15,530
﹤0.01% 956
2019
Q2
$543K Buy
15,530
+3
+0% +$97 ﹤0.01% 950
2019
Q1
$455K Sell
15,527
-2,050
-12% -$58.1K ﹤0.01% 993
2018
Q4
$452K Sell
17,577
-7,660
-30% -$265K ﹤0.01% 940
2018
Q3
$888K Hold
25,237
0.01% 782
2018
Q2
$1.03M Sell
25,237
-4,070
-14% -$164K 0.01% 715
2018
Q1
$1.15M Sell
29,307
-4,335
-13% -$159K 0.01% 677
2017
Q4
$1.1M Sell
33,642
-17,633
-34% -$611K 0.01% 722
2017
Q3
$2.45M Buy
51,275
+38,406
+298% +$1.87M 0.02% 507
2017
Q2
$635K Buy
12,869
+4,524
+54% +$200K ﹤0.01% 897
2017
Q1
$365K Buy
+8,345
New +$339K ﹤0.01% 1005

Other funds holding ACHC

William Blair & Company's ACHC Position: Q4 2024 in Review

William Blair & Company sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 12,723 shares — an estimated $807K sold.

William Blair & Company first reported a position in ACHC in Q1 2017 and held it in 30 quarters. The position peaked at $2.45M in Q3 2017. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • William Blair & Company reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • William Blair & Company sold 12,723 Acadia Healthcare shares in Q4 2024, an estimated $807K.
  • William Blair & Company first reported a position in Acadia Healthcare in Q1 2017 and held it in 30 quarters.
  • William Blair & Company's Acadia Healthcare position peaked at $2.45M in Q3 2017.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on William Blair & Company's 13F filing for Q4 2024, filed 12 Feb 2025.